國立高雄大學圖資館 |

Language: English

Back

Pulmonomics: omics approaches for understanding pulmonary diseases

Record Type:	Electronic resources : Monograph/item
Title/Author:	Pulmonomics: omics approaches for understanding pulmonary diseasesby Sudipto Saha, Sreyashi Majumdar, Parthasarathi Bhattacharyya.
Author:	Saha, Sudipto.
other author:	Majumdar, Sreyashi.
Published:	Singapore :Springer Nature Singapore :2023.
Description:	xiii, 405 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	LungsDiseases
Online resource:	https://doi.org/10.1007/978-981-99-3505-5
ISBN:	9789819935055$q(electronic bk.)

Pulmonomics: omics approaches for understanding pulmonary diseases
Saha, Sudipto.

Pulmonomics: omics approaches for understanding pulmonary diseases[electronic resource] /by Sudipto Saha, Sreyashi Majumdar, Parthasarathi Bhattacharyya. - Singapore :Springer Nature Singapore :2023. - xiii, 405 p. :ill., digital ;24 cm.

Chapter 1_Introduction to Pulmonary Diseases and OMICS approaches -- Chapter 2_Obstructive Pulmonary Diseases -- Chapter 3_COPD (Chronic Obstructive Pulmonar Diseases) -- Chapter 4_ Asthma -- Chapter 5_Other obstructive airway diseases like Bronchiectases, Focal airway narrowing -- Chapter 6_Restrictive Pulmonary Diseases (Common qualities and features with examples) -- Chapter 7_Interstitial Pulmonary fibrosis (IPF) -- Chapter 8_Sarcoidosis -- Chapter 9_ Other restrictive airway diseases like pneumonitis, pleural thickening -- Chapter 10_Vascular Diseases -- Chapter 11_Pulmonary hypertension -- Chapter 12_Pulmonary edema -- Chapter 13_ Other vascular diseases like Pulmonary Edema, Cor Pulmonale -- Chapter 14_Infectious Diseases -- Chapter 15_Tuberculosis -- Chapter 16_Cystic fibrosis -- Chapter 17_Pneumonia, COVID-19 and others -- Chapter 18_Neoplastic Diseases/Lung Cancer.

This book comprehensively reviews various omics approaches like genomics, proteomics, transcriptomics, and metabolomics for understanding pulmonary disease at molecular and systems levels. The initial chapters present the pathogenesis of major pulmonary diseases, namely, obstructive diseases, restrictive diseases, vascular diseases, infectious diseases, and neoplastic carcinoma. The book chapters provide current information about the role of the microbiome and applications of medical imaging, bioinformatics tools, and databases for diagnosis and designing treatment strategies against complex lung diseases. Further, the book discusses omics technologies to identify biomarkers for the early diagnosis and prognosis of pulmonary diseases. Finally, the book elucidates the multi-omics approaches and data integration using mathematical modeling for insights into the disease etiology towards improving the prognostics and predictive accuracy of disease phenotypes.

ISBN: 9789819935055$q(electronic bk.)

Standard No.: 10.1007/978-981-99-3505-5doiSubjects--Topical Terms:

483759
Lungs
--Diseases

LC Class. No.: RC756 / .S243 2023

Dewey Class. No.: 616.24

Pulmonomics: omics approaches for understanding pulmonary diseases
LDR:02904nmm a2200325 a 4500 001 651792
003 DE-He213
005 20231101103832.0
006 m d
007 cr nn 008maaau
008 240327s2023 si s 0 eng d
020 $a 9789819935055$q(electronic bk.)
020 $a 9789819935048$q(paper)
024 7 $a 10.1007/978-981-99-3505-5 $2 doi
035 $a 978-981-99-3505-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC756 $b .S243 2023
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 616.24 $2 23
090 $a RC756 $b .S131 2023
100 1 $a Saha, Sudipto. $3 962172
245 1 0 $a Pulmonomics: omics approaches for understanding pulmonary diseases $h [electronic resource] / $c by Sudipto Saha, Sreyashi Majumdar, Parthasarathi Bhattacharyya.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a xiii, 405 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1_Introduction to Pulmonary Diseases and OMICS approaches -- Chapter 2_Obstructive Pulmonary Diseases -- Chapter 3_COPD (Chronic Obstructive Pulmonar Diseases) -- Chapter 4_ Asthma -- Chapter 5_Other obstructive airway diseases like Bronchiectases, Focal airway narrowing -- Chapter 6_Restrictive Pulmonary Diseases (Common qualities and features with examples) -- Chapter 7_Interstitial Pulmonary fibrosis (IPF) -- Chapter 8_Sarcoidosis -- Chapter 9_ Other restrictive airway diseases like pneumonitis, pleural thickening -- Chapter 10_Vascular Diseases -- Chapter 11_Pulmonary hypertension -- Chapter 12_Pulmonary edema -- Chapter 13_ Other vascular diseases like Pulmonary Edema, Cor Pulmonale -- Chapter 14_Infectious Diseases -- Chapter 15_Tuberculosis -- Chapter 16_Cystic fibrosis -- Chapter 17_Pneumonia, COVID-19 and others -- Chapter 18_Neoplastic Diseases/Lung Cancer.
520 $a This book comprehensively reviews various omics approaches like genomics, proteomics, transcriptomics, and metabolomics for understanding pulmonary disease at molecular and systems levels. The initial chapters present the pathogenesis of major pulmonary diseases, namely, obstructive diseases, restrictive diseases, vascular diseases, infectious diseases, and neoplastic carcinoma. The book chapters provide current information about the role of the microbiome and applications of medical imaging, bioinformatics tools, and databases for diagnosis and designing treatment strategies against complex lung diseases. Further, the book discusses omics technologies to identify biomarkers for the early diagnosis and prognosis of pulmonary diseases. Finally, the book elucidates the multi-omics approaches and data integration using mathematical modeling for insights into the disease etiology towards improving the prognostics and predictive accuracy of disease phenotypes.
650 0 $a Lungs $x Diseases $x Pathogenesis. $3 483759
650 1 4 $a Biomedical Research. $3 243625
650 2 4 $a Genetics and Genomics. $3 827523
650 2 4 $a Bioinformatics. $3 194415
700 1 $a Majumdar, Sreyashi. $3 962173
700 1 $a Bhattacharyya, Parthasarathi. $3 962174
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-99-3505-5
950 $a Biomedical and Life Sciences (SpringerNature-11642)